Ramy Younes

Patients

The podcast welcomes Dr Ramy Younes, corporate VP, global head of clinical development, cardiorenalmetabolism, at Boehringer Ingelheim.

News

Agios Pharma has said it will halt clinical development of tebapivat, a PK activator that had reached phase 2 testing in sickle cell disease.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.